You are here : Home > Funding & TTO > Europe > Research & Innovation Actions ... > Projets financés par les programmes Innovative Medicines Initiative (IMI)

Projects funded by the Innovative Medicines Initiative (IMI) programmes

IMI is the world's biggest public-private partnership (PPP) in the life sciences. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).

Published on 4 May 2021

The goal of IMI, particularly in its second phase (IMI2, 2014-2020) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. To learn more about IMI: https://www.imi.europa.eu/

IMI2 is part of the Horizon 2020 programme (Research and Innovation Actions - RIA).